EFSA Cuts Selenium Upper Limit to 255 µg a Day

EFSA has lowered the tolerable upper intake level for selenium from 300 to 255 µg a day, and published a separate opinion on supplemental DHA. These are pre-legislative signals that usually precede EU maximum level rules by 12 to 24 months, and Germany’s BfR already sets stricter national selenium caps.
EU Clears 34 Probiotic Strains From Novel Food Authorisation

The European Commission has updated its Novel Food Catalogue to classify 34 probiotic strains as not novel in food and supplements. For brands using those strains, no Novel Food authorization is needed, removing an 18 to 24 month step. The Catalogue is advisory, so verify your strains against the authorization list.
EFSA Finds No Safe Level for Berberine at Any Dose: EU Prohibition Is Now the Likely Outcome

EFSA’s preliminary review has found no safe intake level for berberine at any dose, with a final opinion due early 2027 likely to trigger an EU-wide prohibition. Brands selling berberine supplements in Europe should plan reformulation ahead of that opinion.
EU Vitamin and Mineral Dose Limits: Public Consultation Opens Q3 2026

The EU Commission opens a public consultation on harmonised vitamin and mineral maximum permitted levels in Q3 2026, with a draft regulation due Q1 2028. High-dose B vitamins, vitamin D and sports nutrition products face the most reformulation risk.
Luxembourg Rewrites Its Vitamin and Mineral Supplement Caps

Luxembourg has revised its national maximum permitted levels for vitamins and minerals in food supplements. Vitamin C rises to 1,000mg a day and vitamin D to 50 micrograms, several B vitamin caps are removed, and sodium is cut from 5,100mg to 2,000mg. The changes apply in Luxembourg only.
Britain’s Ashwagandha Safety Review Is Still Not Closed

The UK Committee on Toxicity discussed a third draft statement on ashwagandha on 8 September 2026, so the formal risk assessment remains open and no UK or EU conclusion has been published. A separate 90-day study of one branded extract in 62 adults reported no adverse signals, but it was supplier-funded.
EFSA Confirmed Beta-NMN Is Safe. Brands Still Can’t Sell It in the EU Without Approval

EFSA confirmed beta-NMN is safe at 300mg/day in May 2026, but EU Novel Food authorization is still needed before NMN supplements can be marketed in Europe.
EU Decision on Monacolin K Restrictions Due Later in 2026. Red Yeast Rice Brands Take Note

EU final decision on monacolin K expected in 2026. Brands selling red yeast rice supplements in Europe face elevated regulatory risk.
EFSA Clears β-NMN – What the Positive Safety Opinion Means for Supplement Brands

EFSA issued a positive safety opinion on EffePharm’s β-NMN in Q2 2026, opening the EU novel food authorisation pathway for this popular NAD+ precursor supplement. Full EC authorisation is still pending Official Journal publication, so NMN remains technically unauthorised in the EU — brands already selling it into European markets should review their compliance exposure now.
Netherlands Confirms Intent to Ban Ashwagandha -What Supplement Brands Must Do Now

The Dutch Ministry of Health confirmed its intent to ban ashwagandha on 10 April 2026, with no effective date yet set. Denmark already bans leaf-derived ashwagandha and France has an ANSES advisory. Supplement brands with Netherlands-based EU fulfillment should assess affected products and a realistic effective date now.